CVIA Journal

Cardiovascular Innovations and Applications

29th great wall International conference GWICC

GW-ICC Pre-Registration Ends 20th August 2018

GW-ICC Pre-Registration Ends 20th August 2018register now button

Don’t Miss this Opportunity to Enjoy Discounted (Up To 25%) Registration Fees

The 29th Great Wall International Congress of Cardiology (GW-ICC) takes place from 11th -14th October 2018 in Beijing, China.

The conference is jointly hosted by more than twenty Chinese and international cardiovascular organizations covering thirteen academic fields over sixty areas of expertise; and will include more than 400 seminars, training workshops, exhibitions and joint forums that are hosted in conjunction with respected international cardiology associations.

The conference will welcome more than one thousand international delegates from over forty countries; over two thousand Chinese cardiologists and over seventeen thousand other delegates who will share and learn from cutting edge research and innovation in cardiology and related fields.

Opening Ceremony: Keynote Presentations

At the opening ceremony, the following distinguished speakers will deliver keynote presentations:

Building Regional Systems of care for STEMI–how can we improve?

Valentine-C-MichaelMichael Valentine, MD, FACC, ACC President

Dr. Valentine is a senior cardiologist at the Stroobants Cardiovascular Center of Centra Health in Lynchburg, Virginia, USA and has previously served on the ACC’s board of trustees and advocacy committee and as the Virginia chapter governor and board of governors’ chair. He graduated from the University of Virginia School of Medicine. Dr. Valentine has special training and interest in pacing, electrophysiology and interventional cardiology.

New therapeutic targets in atrial fibrillation

Barbara CasadeiBarbara Casadei, MD DPhil FRCP FMedSci FESC, President Elect of the European Society of Cardiology

Professor Casadei is currently Deputy Head of Division of Cardiovascular Medicine in Oxford. Professor Casadei provides a clinical service at the Oxford University Hospitals NHS Trust’s John Radcliffe Hospital and leads a bench-to-bedside translational research programme focussed on atrial fibrillation, which spans from clinical trials to bench-based investigation in human tissue and cells.

Atrial Fibrillation: Global Challenges and Opportunities

Ivor J. Benjamin, MD, FACC, FAHA, President Elect of the AHA

Dr. Ivor J. Benjamin, is currently professor of medicine and director of the Cardiovascular Center at Froedtert Hospital and the Medical College of Wisconsin, USA. Dr Benjamin received his medical degree from Johns Hopkins University School of Medicine and has been in practice for more than 20 years.

The global challenge of heart attacks and strokes – resolve to treat hypertension

David WoodDavid Wood, MB ChB, MSc, FRCP, FRCPE, FFPHM, FESC, President World Heart Federation

Professor Wood is currently Garfield Weston Professor of Cardiovascular Medicine and Honorary Consultant Cardiologist, National Heart and Lung Institute, Imperial College London, United Kingdom. Professor Wood has contributed to international policy and guidelines on cardiovascular disease (CVD) prevention through the World Health Organization, World Heart Federation and the European Society of Cardiology. He was a founder and President of the European Association for Cardiovascular Prevention and Rehabilitation and a Board member of the European Society of Cardiology.

New Frontiers in Health: The Heart and The Brain

valentin fusterValentin Fuster, MD, PhD, Editor-in-Chief of Journal of the American College of Cardiology

After qualifying in medicine at the University of Barcelona, Dr Fuster continued his studies in the United States. Currently he serves The Mount Sinai Medical Hospital as Physician-in-Chief, as well as Director of Mount Sinai Heart, the Zena and Michael A. Wiener Cardiovascular Institute and the Marie-Josée and Henry R. Kravis Center for Cardiovascular Health and is CEO of the National Center for Cardiovascular Research (CNIC). He is also the Richard Gorlin, MD/Heart Research Foundation Professor, Icahn School of Medicine at Mount Sinai. Dr Fuster has made significant contributions throughout his professional career to the advancement of cardiology research, the prevention and treatment of cardiovascular disease, particularly coronary artery disease, atherosclerosis and thrombosis.

Cardiovascular Disease: Yesterday, Today, and Tomorrow

joseph hillJoseph Hill, MD, PhD, Editor-in-Chief of Circulation

Dr Joseph Hill is Chief of UT Southwestern Medical Center’s Division of Cardiology and Director of the Harry S. Moss Heart Center, Dallas, TX, USA. Dr Hill’s research focuses on molecular mechanisms of structural, functional, and electrophysiological remodeling in cardiac hypertrophy and heart failure. He earned his medical and doctoral (pharmacology) degrees at Duke University, completed fellowships with the Institut Pasteur in Paris and the Brigham and Women’s Hospital, Harvard Medical School.

 

Acute Coronary Syndromes: What we have achieved, what remains to be don

thomas luscherThomas F. Lüscher, M.D., F.R.C.P., Editor-in-Chief of European Heart Journal

Professor Thomas F. Lüscher is the Director of Research, Education & Development and Consultant of Cardiology at Royal Brompton & Harefield Hospital Trust and Imperial College, London, United Kingdom and Director of the Center for Molecular Cardiology at the University Zurich, Switzerland. Professor Lüscher is a board certified internist and cardiologist with training in internal medicine at the University Hospital Zurich, cardiovascular physiology and cardiology at the Mayo Clinic, Rochester, MN, USA and in cardiology and clinical pharmacology at the University Hospital Basel, Switzerland. Prior to his current position he was Professor of Pharmacotherapy at the University of Basel, then Professor and vice-chairman of cardiology at the Inselspital of the University of Berne, Switzerland.

Further information on the 29th GW-ICC, to be held 11th -14th October, 2018, in Beijing, China, is available on the congress website:

www.gw-icc2018.org

Email: secretariat@cardiounion.cn

About Beijing

Beijing, the capital of China, features modern architecture, infrastructure and technology alongside historic landmarks and monuments, set against traditions and a culture that evolved from 5,000 years of civilization. From the world famous Olympic Bird’s Nest Stadium (China National Stadium) to the Forbidden City, Beijing has a wealth of treasures for you to discover.

We look forward to welcoming you to Beijing!

Cardiovascular Innovations and Applications (CVIA) is the official journal of the Great Wall International Cardiology Conference (GW-ICC). CVIA supports GW-ICC in its aims of leading the development of cardiovascular medicine in China, by introducing and promoting new concepts and technologies and strengthening and promoting cooperation amongst Chinese and international cardiology experts. CVIA is available on the IngentaConnect platform http://www.ingentaconnect.com/content/cscript/cvia and at http://cvia-journal.org/. Submissions may be made using Scholar One manuscripts at https:/mc04.manuscriptcentral.com/cvia-journal. There are no author submission or article processing fees.

Twitter: @CVIA_Journal

Facebook: https://www.facebook.com/cvia.journal/

Updated: July 31, 2018 — 11:26 am
Cardiovascular Innovations and Applications is indexed in the ESCI, OCLC, Primo Central (Ex Libris), Sherpa Romeo, NISC (National Information Services Corporation), DOAJ and Index Copernicus Databases
EX-Lib-90x50 OCLC-90x50 sherpa NISC logo
Directory of Open Access Journals index-copernicus logo
CVIA Journal © 2015